Trials / Completed
CompletedNCT07089979
Effectiveness of Glunovo Real-Time Continuous Glucose Monitoring in Adults With Type 2 Diabetes
A Randomized Study of the Glunovo Real-Time Continuous Glucose Monitoring (CGM) Effectiveness on Metabolic Control in Patients With Type 2 Diabetes (T2D)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 260 (actual)
- Sponsor
- University of Milan · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The study aims to evaluate the effectiveness of the novel Real-Time Continuous Glucose Monitoring (RT-CGM) system "Glunovo" in improving glycemic control and patient-reported outcomes in individuals with poorly controlled Type 2 Diabetes (T2D).
Detailed description
This is a prospective, open-label, randomized controlled trial involving 165 adult patients with T2D recruited at the Fatebenefratelli-Sacco Hospital in Milan. Participants were randomized in a 1:1 ratio to either the intervention group (RT-CGM with Glunovo) or the control group (standard Self-Monitoring of Blood Glucose \[SMBG\] using conventional glucometers). The primary outcome is the change in Glycated Hemoglobin (HbA1c) levels after 6 months of follow-up. Secondary outcomes include Continuous Glucose Monitoring (CGM)-derived metrics-such as Glucose Management Indicator (GMI), Time in Range (TIR), Time Above Range (TAR), and Time Below Range (TBR)-as well as patient well-being, assessed using the WHO-5 Well-Being Index and a satisfaction scale. The study is designed to assess whether the Glunovo RT-CGM system can support better metabolic control and improve patient experience compared to conventional SMBG methods.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Glunovo CGM device | Group 1 (Subjects that will use Glunovo CGM device) will be compared to Group 2 (subject that will use their glucometer) |
| DEVICE | BG-meter | BG-meter |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2024-07-01
- Completion
- 2024-07-15
- First posted
- 2025-07-29
- Last updated
- 2025-07-29
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT07089979. Inclusion in this directory is not an endorsement.